Biopharmaceutical executives are demonstrating their highest level of confidence in the industry’s growth prospects in four years, a significant turnaround…
Read More
The Biotech Sector Navigates a Shifting Landscape of Funding, Regulation, and Innovation
Following a significant investment slump that began after the initial surge of capital during the early COVID-19 pandemic, the biotechnology…
Read More
Jazz Pharmaceuticals and AbCellera Forge Strategic Alliance to Pioneer Novel T-cell Engaging Antibodies for Gastrointestinal and Solid Tumors
Jazz Pharmaceuticals and AbCellera have announced a significant preclinical research, option, and license agreement, poised to accelerate the discovery and…
Read More
Protecting innovation in a borderless pharma economy: The reality of globalized pharma innovation
Modern pharmaceutical drug development programs are intrinsically global, spanning continents and leveraging distributed expertise. From the initial discovery of a…
Read More
UniQure Secures Path to Regulatory Review for Groundbreaking Huntington’s Disease Gene Therapy After FDA Reversal
UniQure has announced a significant turning point in its pursuit of regulatory approval for AMT-130, a pioneering gene therapy aimed…
Read More
Eli Lilly’s Retatrutide Achieves Unprecedented Weight Loss in TRIUMPH-1 Trial, Signaling New Era in Obesity Pharmacotherapy
NEW ORLEANS, LOUISIANA – At the 86th Scientific Sessions of the American Diabetes Association (ADA) held in New Orleans, Louisiana,…
Read More
Biopharma M&A Surges as Billion-Dollar Deals Fuel Pipeline Replenishment Amidst Patent Cliff Pressures
The biopharmaceutical industry is experiencing a significant resurgence in merger and acquisition (M&A) activity, driven by a wave of high-value…
Read More
AI Transforms Pharmaceutical Regulatory Submissions: Predictive Intelligence and End-to-End Pipelines Emerge as Game-Changers
The pharmaceutical industry is undergoing a profound transformation driven by the rapid integration of Artificial Intelligence (AI), moving beyond early-stage…
Read More
Top pharma companies set sustainability goals, but emissions are still increasing.
The global healthcare industry, a cornerstone of human well-being, faces a profound paradox: while dedicated to improving health, its operational…
Read More
Vedana Therapeutics Secures $46 Million Series A to Advance Next-Generation Migraine Prevention Therapies Targeting PACAP
Seattle-based biotech firm Vedana Therapeutics has successfully closed a $46 million Series A financing round, a significant infusion of capital…
Read MoreYOU MAY HAVE MISSED
